Robert Half Reports Significant Q4 and Full-Year Earnings Decline, Exceeds Guidance
RHI is trading near its 52-week low of $25.22 (9.0% above the low) on elevated volume (1.9× avg).
Summary
Robert Half Inc. announced fourth-quarter and full-year 2025 financial results, showing significant year-over-year declines in revenue and EPS, but exceeding previous guidance and noting positive sequential growth.
Key Events · Earnings and Guidance · RHI
-
Q4 2025 Earnings Decline
Net income for the fourth quarter of 2025 was $32 million, or $0.32 per share, a notable decrease from $54 million, or $0.53 per share, in Q4 2024.
-
Q4 2025 Revenue Decrease
Fourth-quarter 2025 revenues fell to $1.302 billion, down 6% from $1.382 billion in the same period last year.
-
Full-Year Financial Performance
For the full year 2025, net income was $133 million ($1.33 per share) on revenues of $5.379 billion, compared to $252 million ($2.44 per share) on revenues of $5.796 billion in 2024.
-
Exceeded Guidance and Sequential Growth
Management reported that Q4 revenues and earnings exceeded the midpoint of their previous guidance and noted positive sequential growth in talent solutions and enterprise revenues for the first time in over three years, with momentum extending into January.
Analysis · RHI · Trade & Services
Robert Half Inc. reported a substantial year-over-year decline in both revenue and net income for the fourth quarter and full year 2025. While the absolute numbers are down, management highlighted positive sequential growth in talent solutions and enterprise revenues, marking the first time in over three years. Crucially, the company's revenues and earnings surpassed the midpoint of its prior guidance, suggesting a better-than-expected performance despite the overall downturn. Investors will likely weigh the significant annual decline against the signs of stabilization and sequential improvement.
At the time of this filing, RHI was trading at $27.50 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $25.22 to $70.35. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.